期刊文献+

4-苄基哌啶类拮抗剂选择性识别hCCR3的分子模拟 被引量:2

Molecular Modeling Studies on the Selectivity of 4-Benzylpiperidine Antagonists for hCCR3
下载PDF
导出
摘要 以牛视网膜紫质X射线衍射晶体结构为模板,参考定位突变实验数据,采用配体支持同源模建(Ligand-supported homology modeling)方法构建了拮抗剂键合(Antagonist-bound)的人类趋化因子受体hCCR3和hCCR1的三维结构模型.将一系列1,4-二取代哌啶类拮抗剂分别对接进优化后的hCCR3和hCCR1模型中,以配体在hCCR3中的结合自由能理论值对-lgIC50值进行线性回归,确定性系数r2为0.94.分析对接结果发现,配体主要通过疏水芳香作用与hCCR3结合,而4-苄基哌啶类拮抗剂对hCCR3产生选择性的主要原因在于配体的哌啶环与hCCR3中Tyr255(TM7)的苯酚侧链产生面对面的范德华作用,而且hCCR3中处于结合口袋的EL2区的疏水性也为拮抗剂对hCCR3的选择性做出了贡献. The "antagonist-bound" three-dimensional models of the hCCR3 and hCCR1 receptors were constructed by homology modeling,using the X-ray structure of bovine rhodopsin as the template,and refined with molecular modeling and molecular dynamics(MM/MD) methods.We also carried out an automated docking of several 1,4-disubstituted piperidine antagonists into the hCCR3 and hCCR1 model.The binding hypothesis and the reliability of the hCCR3 model were confirmed by the reasonable correlation between the estimated binding free energy and the experimental-lgIC50 values(r^2=0.94).The docking results reveal that the face-to-face van der Waals interaction between piperidine ring and Tyr255 plays an important role on the selectivity of 4-phenzylpiperidine antagonists to hCCR3.Simultaneously,the more hydrophobic of the EL2 in hCCR3 is favorable for the selectivity of 4-phenzylpiperidine antagonists.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2010年第8期1636-1642,共7页 Chemical Journal of Chinese Universities
基金 吉林大学超分子结构与材料国家重点实验室开放课题基金资助
关键词 hCCR3 hCCR1 4-苄基哌啶类拮抗剂 疏水性 分子模拟 hCCR3 hCCR1 4-Phenzylpiperidine antagonist Hydrophobicity Molecular modeling
  • 相关文献

参考文献30

  • 1Elias J.A.,Lee C.G.,Zheng T.,Ma B.,Homer R.J.,Zhu Z..J.Clin.Invest.[J],2003,111:291-297.
  • 2李善玉,范佳,席景会,张海玉,杜宏伟,周欣,王旭,宁波,刘兰英,郝东云.哮喘大鼠淋巴细胞蛋白质组的分析[J].高等学校化学学报,2007,28(9):1696-1700. 被引量:3
  • 3Luster A.D..N.Engl.J.Med.[J],1998,338:436-445.
  • 4Baggiolini M.,Dewald B.,Moser B..Annu.Rev.Immunol.[J],1997,15:675-705.
  • 5Murphy P.M.,Baggiolini M.,Charo I.F.,Hébert C.A.,Horuk R.,Matsushima K.,Miller L.H.,Oppenheim J.J.,Power C.A..Pharmacol.Rev.[J],2000,52:145-176.
  • 6Ponath P.D.,Qin S.,Ringler D.J.,Clark-Lewis I.,Wang J.,Kassam N.,Smith H.,Shi X.,Gonzalo J.A.,Newman W.,Gutierrez-Ramos J.C.,Mackay C.R..J.Clin.Invest.[J],1996,97:604-612.
  • 7Uguccioni M.,Mackay C.R.,Ochensberger B.,Loetscher P.,Rhis S.,LaRosa G.J.,Rao P.,Ponath D.P.,Baggiolini M.,Dahinden A.C..J.Clin.Invest.[J],1997,100:1137-1143.
  • 8Sallusto F.,Mackay C.R.,Lanzavecchia A..Science[J],1997,277:2005-2007.
  • 9Pruitt J.R.,Batt D.G.,Wacker D.A.,Bostrom L.L.,Booker S.K.,McLaughlin E.,Houghton G.C.,Varnes J.G.,Christ D.D.,Covington M.,Das A.M.,Davies P.,Graden D.,Kariv I.,Orlovsky Y.,Stowell N.C.,Vaddi K.G.,Wadman E.A.,Welch P.K.,Yeleswaram S.,Solomon K.A.,Newton R.C.,Decicco C.P.,Carter P.H.,Ko S.S..Bioorg.Med.Chem.Lett.[J],2007,17:2992-2997.
  • 10Morokata T.,Suzuki K.,Masunaga Y.,Taguchi K.,Morihira K.,Sato I.,Fujii M.,Takizawa S.,Torii Y.,Yamamoto N.,Kaneko M.,Yamada T.,Takahashi K.,Shimizu Y..J.Pharmacol.Expt.Ther.[J],2006,317:244-250.

二级参考文献24

  • 1Boushey H.A,Fahy J.V.Environ.Health Perspect[J],1995,103:229-233.
  • 2Holgate S.T,Holloway J,Wilson S,et al.Proc.Am.Thorac.Soc.[J],2004,1:93-98.
  • 3Malmstrom J,Tufvesson E,Lofdahl C.G,et al.Electrophoresis[J],2003,24:276-285.
  • 4Rosengren A.T,Nyman T.A,Lahesmaa R.Proteomics[J],2005,5:3137-3141.
  • 5Linn R,Dupont B.R,Knight C.B,et al.Cell Genet.[J],1996,72:159-161.
  • 6Pelegrf C,Rodriguez-Palmero M,Morante M.P,et al.J.Immunol.Methods[J],1995,187:265-271.
  • 7Gorg A,Postel W,Gunther S.Eleetrophoresis[J],1988,9:531-546.
  • 8cote H.C,Lord S.T,Pratt K.P.Blood[J],1998,92:2195-2212.
  • 9Bromley I.M,Donaldson K.Thorax[J],1996,51:1203-1209.
  • 10Pizzichini M.M,Pizzichini E,Efthimiadis A,et al.Am.J.Respir.Crit.Care Med.[J],1998,158:1178-1184.

共引文献2

同被引文献100

  • 1Barnard E. A. . Trends Biochem. Sci. [J], 1992, 17: 368-374.
  • 2Ci S. Q. , Ren T. R. , Ma C. X. , Su Z. G. . J. Mol. Graph. Model. [J], 2007, 26: 537-545.
  • 3Korpi E. R. , Grunder G. , Luddens H. . Prog. Neurobiol. [J], 2002, 67: 113-159.
  • 4Minier F. , Sigel E. . PNAS[J], 2004, 101: 7769-7774.
  • 5Andrea C. , Germano G. , Salvatore V. , Maurizio A. , Salvatore V. , Gianluca G. , Cristiana S. , Elisabetta M. , Giovanni B. , Alessan-dra C. . Bioorg. Med. Chem. [J], 2008, 16: 3428-3437.
  • 6Stkphane M. J. , Pascal C. , Catherine R. , Daniel G. , Danielle V. G. , Jacques C. , Pierre B. , Pierre T. . Med. Chem. [J], 1994,37: 2153-2160.
  • 7Cox E. D. , HDiaz-Arauzo H. , Huang Q. , Reddy M. S. , Ma C. R. , Harris B. , McKernan R. , Skolnick P. , Cook J. M. . Med.Chem. [J], 1998, 41: 2537-2552.
  • 8Huang Q. , He X. H. , Ma C. H. , Liu R. Y. , Yu S. , Dayer C. A. , Wenger G. R. , McKernan R. , Cook J. M. . Med. Chem. [J],2000, 43: 71-95.
  • 9Mohammad S. A. , Ryu K. , Hiromi H. , Kong X. Y. , Ozoe F. , Yoshihisa M. , Fumio M. , Ozoe Y. . J. Agric. Food Chem. [J],2006, 54: 1361-1372.
  • 10Zhang P. W. , Zhang W. J. , Liu R. Y. , Harris B. , Skolnick P. , Cook J. M. . Med. Chem. [J], 1995, 38: 1679-1688.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部